JP2017500030A5 - - Google Patents

Download PDF

Info

Publication number
JP2017500030A5
JP2017500030A5 JP2016538531A JP2016538531A JP2017500030A5 JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5 JP 2016538531 A JP2016538531 A JP 2016538531A JP 2016538531 A JP2016538531 A JP 2016538531A JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5
Authority
JP
Japan
Prior art keywords
acid sequence
seq
set forth
nucleic acid
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016538531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017500030A (ja
JP7078350B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2013/075137 external-priority patent/WO2014093894A2/en
Application filed filed Critical
Priority claimed from PCT/US2014/070188 external-priority patent/WO2015089492A2/en
Publication of JP2017500030A publication Critical patent/JP2017500030A/ja
Publication of JP2017500030A5 publication Critical patent/JP2017500030A5/ja
Priority to JP2021108614A priority Critical patent/JP2021166534A/ja
Application granted granted Critical
Publication of JP7078350B2 publication Critical patent/JP7078350B2/ja
Priority to JP2023108341A priority patent/JP2023138998A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016538531A 2012-12-13 2014-12-13 Ｄｎａ抗体構築物及びその使用方法 Active JP7078350B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021108614A JP2021166534A (ja) 2013-12-13 2021-06-30 Ｄｎａ抗体構築物及びその使用方法
JP2023108341A JP2023138998A (ja) 2012-12-13 2023-06-30 Ｄｎａ抗体構築物及びその使用方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361896646P 2013-10-28 2013-10-28
PCT/US2013/075137 WO2014093894A2 (en) 2012-12-13 2013-12-13 Dna antibody constructs and method of using same
USPCT/US2013/075137 2013-12-13
PCT/US2014/070188 WO2015089492A2 (en) 2013-12-13 2014-12-13 Dna antibody constructs and method of using same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2020035240A Division JP2020108381A (ja) 2012-12-13 2020-03-02 Ｄｎａ抗体構築物及びその使用方法
JP2021108614A Division JP2021166534A (ja) 2012-12-13 2021-06-30 Ｄｎａ抗体構築物及びその使用方法

Publications (3)

Publication Number Publication Date
JP2017500030A JP2017500030A (ja) 2017-01-05
JP2017500030A5 true JP2017500030A5 (de) 2018-01-25
JP7078350B2 JP7078350B2 (ja) 2022-05-31

Family

ID=81845563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016538531A Active JP7078350B2 (ja) 2012-12-13 2014-12-13 Ｄｎａ抗体構築物及びその使用方法

Country Status (1)

Country Link
JP (1) JP7078350B2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7387439B2 (ja) 2017-03-20 2023-11-28 ユニバーシティ オブ コペンハーゲン 改良されたｌｉワクチンアジュバント

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013358944B2 (en) * 2012-12-13 2016-08-18 Inovio Pharmaceuticals, Inc. DNA antibody constructs and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636360A4 (de) 2003-06-03 2006-11-08 Cell Genesys Inc Zusammensetzungen und verfahren zur verstärkten expression rekombinanter polypeptide von einem vektor unter verwendung einer peptidspaltstelle
CA2573656A1 (en) * 2004-07-13 2006-02-16 Cell Genesys, Inc. Aav vector compositions and methods for enhanced expression of immunoglobulins using the same
AU2009305113B2 (en) 2008-10-13 2015-07-16 Institute For Research In Biomedicine Dengue virus neutralizing antibodies and uses thereof
AU2013358944B2 (en) 2012-12-13 2016-08-18 Inovio Pharmaceuticals, Inc. DNA antibody constructs and method of using same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7387439B2 (ja) 2017-03-20 2023-11-28 ユニバーシティ オブ コペンハーゲン 改良されたｌｉワクチンアジュバント

Similar Documents

Publication Publication Date Title
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
EA201792573A1 (ru) Триспецифические связанные белки и способы их применения
WO2015188132A8 (en) Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof
JP2016529229A5 (de)
JP2016053091A5 (de)
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
EA201400568A1 (ru) Альбуминсвязывающие антитела и их связывающие фрагменты
RU2021124437A (ru) Конструкции, направленные на комплексы пептида afp/mhc, и виды их использования
HRP20231496T1 (hr) Cistein proteaza
JP2013107899A5 (de)
AR107290A1 (es) ANTICUERPOS PEPTÍDICOS b AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
JP2016501535A5 (de)
PE20211272A1 (es) POLIPEPTIDOS DE IL-22 Y PROTEINAS DE FUSION DE IL-22 Fc Y METODOS DE USO
JP2015212284A5 (de)
BR112013029409A8 (pt) produtos farmacêuticos de peptídeo melhorados para resistência à insulina
BR112015020315A2 (pt) conjugação de anticorpo-fármaco sítio-específica por glicoengenharia
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
JP2014510519A5 (de)
RU2017114673A (ru) Слитый белок, наночастица, состоящая из множества мономеров указанного слитого белка, и их применение
JP2017537621A5 (de)
RU2017132689A (ru) СЛИТАЯ С Fc α-ЦЕПЬ ВЫСОКОАФФИННОГО РЕЦЕПТОРА IgE
JP2016525545A5 (de)
WO2016115511A3 (en) Vegf variant polypeptide compositions
EA201790341A1 (ru) Анти-ск8 антитела для применения в лечении рака